Lakefront Biotherapeutics N.V. (LKFT) Financials

LKFT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 ? -3.7 billion
March 31, 2026 3.9 billion 136.4 million
Dec. 31, 2025 4.0 billion 200.3 million
Sept. 30, 2025 4.1 billion 1.2 billion

LKFT Free Cash Flow and Stock based compensation

No data available :(

LKFT Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 2.4 million
March 31, 2026 16.6 million
Dec. 31, 2025 918.2 million
Sept. 30, 2025 -237.2 million

LKFT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.4 billion - -
March 31, 2026 3.4 billion - 7.4 million
Dec. 31, 2025 3.5 billion - 8.1 million
Sept. 30, 2025 3.6 billion - 8.8 million

LKFT Shares Outstanding

No data available :(

LKFT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 29.1 million 26.1 million 3.2 million
March 31, 2026 140953 35.5 million 40.7 million 3.2 million
Dec. 31, 2025 1.9 million 126.2 million 3.5 million -3.5 million
Sept. 30, 2025 3.3 million 86.7 million 54.5 million 4.6 million

LKFT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 13.8 million 39.5 million
March 31, 2026 7.4 million 5.5 million
Dec. 31, 2025 1.1 billion 534153
Sept. 30, 2025 83.5 million 12.7 million

LKFT

Price: $28.49

52 week price:
25.68
37.78

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.9 billion

Links: